anmelden
NYSE International 100
11.124,45
PKT
-41,56
PKT
-0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.04.24 | BP Outperform | RBC Capital Markets | |
| 09.04.24 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Overweight | Barclays Capital | |
| 09.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 09.04.24 | HSBC Neutral | UBS AG | |
| 09.04.24 | BP Buy | UBS AG | |
| 09.04.24 | Diageo Hold | Jefferies & Company Inc. | |
| 09.04.24 | BP Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.04.24 | SAP Overweight | Barclays Capital | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | Unilever Overweight | Barclays Capital | |
| 08.04.24 | Siemens Outperform | RBC Capital Markets | |
| 08.04.24 | SAP Buy | UBS AG | |
| 08.04.24 | Allianz Neutral | UBS AG | |
| 05.04.24 | Allianz Buy | Jefferies & Company Inc. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | National Grid Buy | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 05.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Eni Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Mercedes-Benz Group (ex Daimler) Buy | Deutsche Bank AG | |
| 05.04.24 | Siemens Underweight | Barclays Capital | |
| 05.04.24 | AXA Overweight | Barclays Capital | |
| 05.04.24 | Allianz Equal Weight | Barclays Capital | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Sanofi Overweight | Barclays Capital | |
| 04.04.24 | GSK Equal Weight | Barclays Capital | |
| 04.04.24 | Rio Tinto Overweight | Barclays Capital | |
| 04.04.24 | BP Buy | UBS AG | |
| 04.04.24 | Deutsche Telekom Overweight | Barclays Capital |
